- Home
- ZLAB vs GPOR Comparison
ZLAB vs GPOR Comparison
Compare ZLAB & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- GPOR
- Stock Information
- Founded
- ZLAB 2013
- GPOR 1997
- Country
- ZLAB China
- GPOR United States
- Employees
- ZLAB N/A
- GPOR N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- GPOR Oil & Gas Production
- Sector
- ZLAB Health Care
- GPOR Energy
- Exchange
- ZLAB Nasdaq
- GPOR Nasdaq
- Market Cap
- ZLAB 3.4B
- GPOR 3.1B
- IPO Year
- ZLAB 2017
- GPOR N/A
- Fundamental
- Price
- ZLAB $36.14
- GPOR $167.62
- Analyst Decision
- ZLAB Buy
- GPOR Buy
- Analyst Count
- ZLAB 3
- GPOR 7
- Target Price
- ZLAB $47.37
- GPOR $210.00
- AVG Volume (30 Days)
- ZLAB 1.3M
- GPOR 275.2K
- Earning Date
- ZLAB 05-07-2025
- GPOR 04-29-2025
- Dividend Yield
- ZLAB N/A
- GPOR N/A
- EPS Growth
- ZLAB N/A
- GPOR N/A
- EPS
- ZLAB N/A
- GPOR N/A
- Revenue
- ZLAB $398,988,000.00
- GPOR $909,219,000.00
- Revenue This Year
- ZLAB $45.57
- GPOR $56.84
- Revenue Next Year
- ZLAB $47.91
- GPOR $10.59
- P/E Ratio
- ZLAB N/A
- GPOR N/A
- Revenue Growth
- ZLAB 49.59
- GPOR N/A
- 52 Week Low
- ZLAB $13.48
- GPOR $130.02
- 52 Week High
- ZLAB $37.99
- GPOR $201.18
- Technical
- Relative Strength Index (RSI)
- ZLAB 64.46
- GPOR 43.18
- Support Level
- ZLAB $34.32
- GPOR $157.46
- Resistance Level
- ZLAB $37.99
- GPOR $167.80
- Average True Range (ATR)
- ZLAB 1.98
- GPOR 6.40
- MACD
- ZLAB 0.02
- GPOR -0.62
- Stochastic Oscillator
- ZLAB 72.51
- GPOR 37.22
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition and production of natural gas, crude oil and NGL in the United States. It operates through Utica Shale and Scoop properties. The Utica Shale is located in the Appalachian Basin of the United States and Canada. The Scoop (South Central Oklahoma Oil Province) play of Oklahoma is located in the southeast portion of the prolific Anadarko Basin.